161 related articles for article (PubMed ID: 17920164)
21. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.
Stark JM; Stark MA; Colasurdo GN; LeVine AM
J Med Virol; 2006 Jun; 78(6):829-38. PubMed ID: 16628585
[TBL] [Abstract][Full Text] [Related]
22. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
[TBL] [Abstract][Full Text] [Related]
23. Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection.
Fischer JE; Johnson JE; Johnson TR; Graham BS
J Infect Dis; 2000 Oct; 182(4):1029-38. PubMed ID: 10979896
[TBL] [Abstract][Full Text] [Related]
24. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
[TBL] [Abstract][Full Text] [Related]
25. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
[TBL] [Abstract][Full Text] [Related]
26. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
[TBL] [Abstract][Full Text] [Related]
27. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles.
Harcourt JL; Anderson LJ; Sullender W; Tripp RA
Vaccine; 2004 Jun; 22(17-18):2248-60. PubMed ID: 15149784
[TBL] [Abstract][Full Text] [Related]
29. Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans.
Huang Y; Anderson R
Vaccine; 2002 Feb; 20(11-12):1586-92. PubMed ID: 11858866
[TBL] [Abstract][Full Text] [Related]
30. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
Dodd JS; Lum E; Goulding J; Muir R; Van Snick J; Openshaw PJ
J Immunol; 2009 Dec; 183(11):7006-13. PubMed ID: 19915054
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
Zhou J; Yang XQ; Xie YY; Zhao XD; Jiang LP; Wang LJ; Cui YX
Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108
[TBL] [Abstract][Full Text] [Related]
32. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
[TBL] [Abstract][Full Text] [Related]
33. Respiratory syncytial virus persistence: evidence in the mouse model.
Mejías A; Chávez-Bueno S; Gómez AM; Somers C; Estripeaut D; Torres JP; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S60-2. PubMed ID: 18820580
[TBL] [Abstract][Full Text] [Related]
34. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model.
Ponnuraj EM; Springer J; Hayward AR; Wilson H; Simoes EA
J Infect Dis; 2003 Apr; 187(8):1257-63. PubMed ID: 12696005
[TBL] [Abstract][Full Text] [Related]
35. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
[TBL] [Abstract][Full Text] [Related]
37. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.
Castilow EM; Meyerholz DK; Varga SM
J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447
[TBL] [Abstract][Full Text] [Related]
38. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
[TBL] [Abstract][Full Text] [Related]
39. Advances in respiratory syncytial virus vaccine development.
Kneyber MC; Kimpen JL
Curr Opin Investig Drugs; 2004 Feb; 5(2):163-70. PubMed ID: 15043390
[TBL] [Abstract][Full Text] [Related]
40. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.
Dakhama A; Lee YM; Ohnishi H; Jing X; Balhorn A; Takeda K; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):138-145.e5. PubMed ID: 19056111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
